Merck Performance Details
Yesterday, I reported that I sold my position in Merck (MRK) in the Fat Pitch Financials Portfolio. I have some additional performance statistics to provide on this trade.
According to Marketocracy, I had a total return of 76.89% on the 5,000 shares of Merck purchased on October 4, 2004. The appreciation in share price alone was 63.19%. The year-to-date return on Merck price was 31.03%.
Here is a look of the cash flows associated with my Merck position in my portfolio:
| Date | Amount |
|
10/4/2004 |
($171,445.80) |
|
1/3/2005 |
$1,900.00 |
|
4/1/2005 |
$1,900.00 |
|
7/1/2005 |
$1,900.00 |
|
10/3/2005 |
$1,900.00 |
|
1/3/2006 |
$1,900.00 |
|
4/3/2006 |
$1,900.00 |
|
7/3/2006 |
$1,900.00 |
|
10/2/2006 |
$1,900.00 |
|
1/2/2007 |
$1,900.00 |
|
4/2/2007 |
$1,900.00 |
|
7/2/2007 |
$1,900.00 |
|
10/1/2007 |
$1,900.00 |
|
11/6/2007 |
$279,780.00 |
|
IRR |
21.2% |
Each of those $1,900 payments came from the $0.38 quarterly dividends issued by Merck. I used Excel’s XIRR function to determine that my annualized rate of return on my Merck position was a solid 21.2%. I’m very happy with that return and look forward to finding another fat pitch opportunity to replace Merck in my portfolio. Any ideas?
Useful Links:
Ahh, Too bad you didn’t hold on to MRK for a few more days